Difference between revisions of "Category:RANK ligand inhibitors"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
A class of drugs that inhibit the receptor activator of nuclear factor kappa-B ligand (RANKL). Currently [[Denosumab (Xgeva)]] is the only FDA-approved drug in this class. | A class of drugs that inhibit the receptor activator of nuclear factor kappa-B ligand (RANKL). Currently [[Denosumab (Xgeva)]] is the only FDA-approved drug in this class. | ||
| − | [[Category: | + | [[Category:Bone protective medications]] |
Latest revision as of 19:56, 27 October 2017
A class of drugs that inhibit the receptor activator of nuclear factor kappa-B ligand (RANKL). Currently Denosumab (Xgeva) is the only FDA-approved drug in this class.
Pages in category "RANK ligand inhibitors"
This category contains only the following page.